CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs

Clinical trial NCT02779530 · COMPLETED

Trial details

NCT number: NCT02779530
Sponsor: Eduardo Barbosa Coelho
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Drug-Related Side Effects and Adverse Reactions

Start date: 2011-10-01
Primary completion: 2013-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.